Join our mailing list and receive the monthly BioVox newsletter for free!

RELATED ARTICLES
Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company…


Why start-ups can become mega companies in the pharma sector

In a previous BioVox article, we analyzed the steps needed for a life sciences start-up to turn into a fully integrated, commercial stage biotech …


How to build a “European Amgen”

There are still very few large European biotech companies to compete with the Amgens and Gileads of the world.  Only a handful of European biotech…

POPULAR TAGS

Trinean wins 25.000 euro for disposables production

Written by DS on in the category news with the tags , , .


Trinean won the “Time for a Boost 2015” competition organized by Test and Measurement Solutions. CEO Kurt Hensen handed a cheque of 25 000 euro to the Ghent University spin-off.

Trinean develops, assembles and commercializes highly-specialized lab instruments and hydrophilic plastic plates for molecular spectroscopy on micro samples. The availability of DNA, RNA, or biological samples (blood, tumor tissue) is often limited. Therefore, the micro-amounts should be used optimally and remain sufficiently pure. Trinean’s plates have a special hydrophilic coating that suck the sample into tiny channels, preventing evaporation.

A strong optical inspection is necessary to guarantee the quality of the plates. Therefore Trinean will implement an automated visual inspection. This will increase the production capacity enormously and will benefit the precision and traceability. Trinean’s products are used worldwide in diagnostic centra and biobanks for sample analysis.

Read more about: , , .

RELATED ARTICLES
Grail: A billion-dollar gamble?

Grail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company…


Why start-ups can become mega companies in the pharma sector

In a previous BioVox article, we analyzed the steps needed for a life sciences start-up to turn into a fully integrated, commercial stage biotech …


How to build a “European Amgen”

There are still very few large European biotech companies to compete with the Amgens and Gileads of the world.  Only a handful of European biotech…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Flanders.bio Turnstone Biowin GSK Itera Life Science UGent KU Leuven V-Bio Ventures XpandInnovation Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.